object
document
ezrinradixinmoesin
erm
phosphoryl
mitogenactiv
protein
kinas
mapk
rhorock
protein
kinas
c
pkc
pathway
lead
filament
actin
factin
reorgan
microvascular
endotheli
cell
hyperperm
studi
investig
effect
xijiao
dihuang
decoct
combin
yinqiao
powder
xdi
influenza
viru
iv
induc
factin
restructur
erm
phosphoryl
regul
rhorho
kinas
rock
mapk
pkc
signal
pathway
pulmonari
microvascular
endotheli
cell
pmvec
method
serum
contain
xdi
xdyc
gkg
acquir
use
standard
protocol
serum
pharmacolog
primari
pmvec
obtain
male
wistar
rat
cultur
adsorpt
iv
multipl
infect
h
medium
xdyc
ad
pmvec
distribut
factin
phosphoryl
erm
determin
confoc
microscopi
factin
express
measur
flow
cytometri
express
level
phosphoryl
myosin
phosphatas
targetsubunit
influenza
viru
iv
preval
viru
caus
respiratori
diseas
worldwid
season
virus
spread
among
human
popul
caus
annual
epidem
lead
approxim
death
per
year
one
major
health
complic
iv
viral
pneumonia
result
acut
respiratori
distress
syndrom
ard
acut
phase
ard
symptom
character
cyanosi
hypoxemia
pulmonari
edema
respiratori
failur
may
ultim
lead
multipl
organ
failur
low
surviv
rate
respiratori
failur
acut
phase
ard
attribut
damag
epithelialendotheli
barrier
pulmonari
alveoli
ga
exchang
take
place
damag
barrier
lead
flood
proteinac
edema
fluid
contain
fibrin
erythrocyt
inflammatori
cell
alveolar
lumen
although
pathogenesi
ard
partial
understood
thought
key
determin
ard
endotheli
barrier
dysfunct
subsequ
pulmonari
microvascular
endotheli
leakag
clinic
analysi
show
mortal
remain
high
among
patient
sever
influenza
despit
use
antivir
therapeut
strategi
suggest
microvascular
leakag
may
play
critic
role
pathogenesi
viral
infect
xijiao
dihuang
decoct
combin
yinqiao
powder
xdi
classic
compound
formula
origin
prescrib
jutong
wu
ancient
chines
physician
qing
dynasti
xdi
clear
heat
remov
toxin
cool
blood
stop
bleed
promot
blood
circul
result
clinic
studi
indic
modifi
yinqiao
powder
could
amelior
symptom
shorten
durat
fever
caus
iv
xijiao
dihuang
decoct
current
refer
qingr
dihuang
decoct
evalu
treatment
bloodheat
syndrom
modern
studi
xijiao
dihuang
decoct
benefici
treat
syndrom
toxin
intrud
blood
phenomenon
occur
sever
acut
respiratori
syndrom
sar
exampl
modifi
xijiao
dihuang
decoct
use
treat
firetoxin
syndrom
caus
viral
pneumonia
virtu
abil
clear
heat
cool
blood
nourish
yin
dispel
phlegm
previou
studi
show
xdi
treatment
clearli
reduc
mortal
rate
decreas
pulmonari
permeabl
allevi
pulmonari
edema
mice
viral
pneumonia
result
vitro
studi
demonstr
xdi
could
protect
endotheli
barrier
revers
permeabl
increas
pmvec
caus
iv
infect
howev
mechan
xdi
mitig
hyperperm
ivinfect
pmvec
requir
investig
ezrinradixinmoesin
erm
protein
form
link
cytomembran
cytoskeleton
integr
cytoskeleton
mediat
erm
phosphoryl
crucial
mainten
endotheli
morpholog
permeabl
well
document
erm
phosphoryl
via
mitogenactiv
protein
kinas
mapk
rhorho
kinas
rock
protein
kinas
c
pkc
pathway
thu
lead
rearrang
filament
actin
factin
hyperperm
microvascular
endotheli
cell
therefor
studi
focus
effect
xdi
factin
rearrang
ivinfect
pmvec
furthermor
explor
underli
mechan
determin
effect
erm
phosphoryl
well
role
activ
rhorock
mapk
pkc
pathway
serv
upstream
activ
erm
protein
dulbecco
modifi
eagl
medium
medium
fetal
bovin
serum
fb
purchas
thermo
fisher
scientif
waltham
usa
endotheli
cell
growth
supplement
ecg
purchas
becton
dickinson
compani
bergen
nj
usa
fluorescein
isothiocyan
labeledphalloidin
phalloidinfitc
purchas
sigmaealdrich
st
loui
mo
usa
reagent
dapi
purchas
boster
wuhan
hubei
china
bovin
serum
albumin
bsa
obtain
amresco
solon
oh
usa
paraformaldehyd
purchas
beij
bioway
biotech
group
beij
china
antibodi
phosphoryl
erm
perm
phosphoryl
pkc
ppkc
obtain
cell
signal
technolog
danver
usa
antibodi
phosphoryl
mapk
kinas
pmkk
phosphoryl
purchas
abcam
cambridg
england
uk
antibodi
phosphoryl
myosin
phosphatas
targetsubunit
pmypt
purchas
abnova
studi
perform
accord
principl
laboratori
anim
care
guidelin
publish
world
health
organ
experi
approv
institut
anim
ethic
committe
beij
univers
chines
medicin
male
wistar
rat
weigh
g
obtain
vital
river
laboratori
beij
china
randomli
divid
group
xdyc
group
rat
administ
xdi
solut
intragastr
gavag
twicedaili
dose
gkg
mlrat
day
dose
equal
time
use
previous
adultdosag
control
serum
con
group
rat
administ
salin
use
treatment
schedul
volum
describ
xdyc
group
hour
last
administr
blood
obtain
abdomin
aorta
store
ae
c
h
serum
isol
centrifug
rpm
minut
inactiv
c
min
store
c
prepar
experi
mouseadapt
iv
strain
purchas
institut
viru
research
chines
center
diseas
control
prevent
propag
embryon
egg
beij
merial
vital
laboratori
anim
technolog
beij
china
tissu
cultureinfecti
dose
tcid
determin
perform
cytopath
effect
cpe
assay
accord
method
reed
muench
tcid
iv
strain
afm
ml
pmvec
infect
iv
multipl
infect
moi
fourweekold
male
wistar
rat
weigh
g
obtain
vital
river
laboratori
beij
china
pmvec
isol
cultur
accord
previou
method
modif
briefli
tissu
sampl
remov
peripheri
fresh
lung
separ
rat
cut
piec
next
lung
piec
place
gelatinco
cell
flask
flask
invert
place
incub
c
co
h
flask
stood
upright
ml
medium
ad
flask
medium
compris
supplement
fb
ecg
mgml
penicillinstreptomycin
solut
incub
tissu
abandon
ml
medium
ad
individu
flask
approxim
confluenc
pmvec
detach
use
edta
subcultur
new
flask
pmvec
identifi
accord
morpholog
function
criteria
confluent
pmvec
first
passag
use
experi
conduct
group
cell
control
group
incub
contain
con
cell
viru
group
infect
iv
moi
hour
incub
contain
con
cell
xdi
group
infect
iv
moi
hour
incub
contain
xdyc
cell
group
incub
h
use
experi
describ
section
wash
pmvec
grow
plate
twice
phosphat
buffer
salin
pb
collect
fix
paraformaldehyd
c
permeabil
cell
label
minut
mgml
phalloidinfitc
sampl
evalu
use
facscanto
flow
cytomet
becton
dickinson
san
jose
ca
data
analyz
use
bd
fac
diva
softwar
pmvec
grown
rs
glass
side
nunc
denmark
wash
pb
fix
use
paraformaldehyd
c
permeabil
use
triton
block
use
bsa
pmvec
incub
antiperm
antibodi
follow
dylight
secondari
antibodi
factin
label
use
phalloidinfitc
mgml
cell
preincub
bsa
imag
collect
confoc
microscop
olympu
japan
xdyc
administr
cell
collect
cell
scraper
lyse
ripa
buffer
lysat
centrifug
c
rpm
min
total
amount
protein
contain
supernat
detect
use
bca
kit
applygen
beij
china
equival
total
protein
sampl
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
electrotransf
onto
pvdf
membran
membran
block
nonfat
milk
hour
c
incub
correspond
primari
antibodi
c
overnight
incub
secondari
antibodi
c
hour
follow
day
immunereact
band
detect
use
ecl
plu
western
blot
detect
kit
wuhan
boster
biotech
group
hubei
china
level
perm
pmkk
pmypt
ppkc
examin
use
correspond
primari
antibodi
dilut
nonfat
milk
respect
result
report
mean
sem
data
analyz
student
test
data
group
use
prism
softwar
version
graphpad
softwar
usa
differ
consid
signific
p
pmvec
control
group
show
normal
spindleshap
morpholog
control
group
continu
factin
distribut
observ
mainli
cortic
area
cell
without
stress
fiber
viru
group
factin
pmvec
reorgan
show
thicken
bundl
cytoplasm
format
thick
stress
fiber
growth
presenc
xdyc
revers
factin
rearrang
observ
ivinfect
pmvec
cytoplasm
factin
accumul
stress
fiber
format
induc
iv
infect
also
allevi
xdyc
treatment
fig
fig
effect
xdyc
ivinduc
factin
reorgan
scale
bar
mm
pmvec
infect
iv
grown
medium
contain
xdyc
h
factin
cytoskeleton
green
nuclei
blue
examin
use
confoc
microscopi
three
independ
experi
perform
triplic
viru
group
factin
express
pmvec
increas
remark
compar
observ
normal
group
p
ivdepend
factin
induct
reduc
xdi
group
howev
differ
viru
group
xdi
group
signific
p
fig
viru
group
perm
level
significantli
increas
compar
observ
control
group
p
differ
perm
level
viru
xdyc
group
statist
signific
impli
xdyc
inhibit
ivinduc
erm
phosphoryl
pmvec
p
fig
weak
fluoresc
detect
perm
pmvec
observ
control
group
perm
reloc
border
show
enhanc
detect
ivinfect
pmvec
compar
observ
control
group
xdyc
treatment
inhibit
ivinduc
perm
express
redistribut
peripheri
pmvec
fig
effect
xdyc
pmkk
product
ivinfect
pmvec
iv
infect
promot
significantli
higher
pmkk
product
pmvec
p
compar
observ
control
group
fig
level
approxim
higher
viru
group
rel
control
group
pmkk
product
approxim
higher
treatment
xdi
significantli
attenu
ivinduc
phosphoryl
p
although
pmkk
product
xdi
group
lower
viru
group
differ
statist
signific
p
data
suggest
xdi
might
inhibit
ivinduc
activ
mapk
pathway
determin
whether
erm
phosphoryl
rho
rock
pathway
whether
phosphoryl
inhibit
xdyc
first
assess
express
western
blot
product
pmypt
also
studi
mypt
main
substrat
rock
regul
myosin
light
chain
phosphatas
mlc
phosphoryl
iv
infect
significantli
increas
pmypt
level
p
compar
control
group
treatment
xdyc
significantli
downregul
virusinduc
pmypt
overexpress
pmvec
p
p
fig
product
ppkc
significantli
increas
iv
infect
p
compar
control
group
expect
xdyc
treatment
significantli
reduc
ppkc
level
ivinfect
pmvec
p
data
indic
xdyc
might
amelior
virusinduc
endotheli
dysfunct
modul
pkc
pathway
fig
disrupt
pulmonari
microvascular
endotheli
barrier
lead
movement
fluid
pulmonari
air
space
ultim
result
ard
acut
lung
injuri
pulmonari
edema
microfila
actin
filament
close
link
vascular
endotheli
permeabl
factin
rearrang
lead
stress
fiber
format
stretch
turn
contribut
paracellular
gap
format
eventu
permeabl
increas
ermfamili
protein
crucial
regul
cell
structur
function
serv
linker
plasma
membran
actin
cytoskeleton
via
ntermin
bind
membraneadhes
molecul
ctermin
bind
actin
conserv
threonin
residu
found
respect
ctermin
region
name
ezrin
radixin
moesin
import
mechan
ermfamili
regul
occur
phosphoryl
respect
conserv
threonin
residu
phosphoryl
conserv
threonin
residu
caus
conform
chang
erm
unmask
bind
site
effector
protein
rho
kinas
mapk
pkc
kinas
thought
phosphoryl
erm
protein
previou
studi
also
provid
evid
kinas
modul
endotheli
cell
permeabl
variou
stimuli
promot
erm
phosphoryl
endotheli
cell
perm
protein
mainli
local
border
pmvec
link
cytoskelet
membran
element
lead
format
stress
fiber
paracellular
gap
eventu
contribut
permeabl
increas
previous
report
erm
phosphoryl
induc
tnfa
may
trigger
permeabl
increas
human
pmvec
via
mapk
pkc
pathway
previou
find
also
show
thrombin
mediat
endotheli
permeabl
increas
erm
phosphoryl
via
pkc
pathway
erm
protein
phosphoryl
via
mapk
rhorock
pathway
also
particip
modul
endotheli
permeabl
induc
advanc
glycat
end
product
previous
show
iv
infect
increas
microvascular
leakag
pmvec
primari
mechan
relat
activ
rhorock
mapk
pkc
pathway
ultim
lead
erm
phosphoryl
xdi
classic
tradit
medicin
use
treat
viral
pneumonia
induc
iv
infect
previous
show
xdi
administr
reduc
mortal
rate
mice
viral
pneumonia
result
prior
studi
demonstr
xdi
reduc
virusinduc
permeabl
increas
well
pulmonari
inflamm
vascular
injuri
induc
iv
addit
confirm
dosag
gkg
equival
clinic
dosag
effect
therefor
gain
insight
mechan
wherebi
xdi
protect
vascular
endothelium
studi
effect
xdysc
mice
clinicaldos
equival
factin
ermrel
pathway
ivinfect
pmvec
studi
xdyc
dramat
reduc
ivinduc
stress
fiber
format
factin
accumul
cytoplasm
howev
differ
factin
express
viru
group
xdi
group
statist
signific
suggest
xdyc
mainli
allevi
factin
rearrang
rather
reduc
express
also
determin
effect
xdyc
phosphoryl
rock
substrat
mypt
previou
data
demonstr
rock
upregul
endotheli
cell
infect
viru
activ
rock
promot
mypt
phosphoryl
thu
activ
mlc
promot
actinfila
polymer
mypt
express
reduc
xdycstreat
pmvec
indic
ivinduc
factin
reorgan
revers
xdyc
via
inhibit
mlc
phosphoryl
integr
endotheli
cell
cytoskeleton
mediat
mlc
phosphoryl
indispens
endotheli
cell
function
mypt
phosphoryl
promot
erm
phosphoryl
suggest
common
pathway
may
share
mlc
erm
therefor
effect
xdyc
factin
reorgan
might
link
mlc
regul
possibl
intend
studi
futur
interestingli
cytoskelet
chang
observ
sole
link
hyperperm
pmvec
also
relat
viru
replic
actin
polymer
augment
ivinfect
cell
accompani
activ
rafmekerk
pkc
pathway
well
calcium
phospholipas
c
product
factin
rearrang
facilit
viral
transport
nucleu
via
gene
regul
activ
factin
transport
system
cytoplasm
although
observ
xdi
inhibit
viral
replic
ivinfect
pmvec
data
shown
might
due
interfer
serum
viru
replic
vitro
detect
reduct
viral
titer
lung
tissu
ivinfect
mice
factin
rearrang
involv
iv
replic
abil
xdi
inhibit
iv
replic
vivo
might
due
capac
revers
ivinduc
factin
reorgan
howev
whether
xdi
inhibit
iv
replic
interf
erm
phosphoryl
remain
unclear
sinc
role
erm
phosphoryl
iv
replic
remain
uncertain
merit
investig
